|
[1]
|
GBD 2019 Benign Prostatic Hyperplasia Collaborators (2022) The Global, Regional, and National Burden of Benign Prostatic Hyperplasia in 204 Countries and Territories from 2000 to 2019: A Systematic Analysis for the Global Burden of Disease Study 2019. The Lancet Healthy Longevity, 3, e754-e776.
|
|
[2]
|
Suskind, A.M. (2017) Frailty and Lower Urinary Tract Symptoms. Current Urology Reports, 18, Article No. 67. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Launer, B.M., McVary, K.T., Ricke, W.A. and Lloyd, G.L. (2021) The Rising Worldwide Impact of Benign Prostatic Hyperplasia. BJU International, 127, 722-728. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Cesari, M., Calvani, R. and Marzetti, E. (2017) Frailty in Older Persons. Clinics in Geriatric Medicine, 33, 293-303. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Searle, S.D., Mitnitski, A., Gahbauer, E.A., Gill, T.M. and Rockwood, K. (2008) A Standard Procedure for Creating a Frailty Index. BMC Geriatrics, 8, Article No. 24. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Zhao, Y., Strauss, J., Chen, X., et al. (2020) China Health and Retirement Longitudinal Study Wave 4 User’s Guide. National School of Development Peking University.
|
|
[7]
|
von Elm, E., Altman, D.G., Egger, M., Pocock, S.J., Gøtzsche, P.C. and Vandenbroucke, J.P. (2007) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies. Annals of Internal Medicine, 147, 573-577. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Ferrucci, L., Guralnik, J.M., Studenski, S., Fried, L.P., Cutler, G.B. and Walston, J.D. (2004) Designing Randomized, Controlled Trials Aimed at Preventing or Delaying Functional Decline and Disability in Frail, Older Persons: A Consensus Report. Journal of the American Geriatrics Society, 52, 625-634. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
World Health Organization (2025) Obesity and Overweight. https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight
|
|
[10]
|
Kozminski, M.A., Wei, J.T., Nelson, J. and Kent, D.M. (2015) Baseline Characteristics Predict Risk of Progression and Response to Combined Medical Therapy for Benign Prostatic Hyperplasia (BPH). BJU International, 115, 308-318. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Bauer, S.R., McCulloch, C.E., Cawthon, P.M., Ensrud, K.E., Suskind, A.M., Newman, J.C., et al. (2023) Longitudinal Associations between Concurrent Changes in Phenotypic Frailty and Lower Urinary Tract Symptoms among Older Men. The Journal of Frailty & Aging, 12, 117-125. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Liu, S., Cao, H., Wang, L., Li, S., Liang, Y., Feng, Y., et al. (2025) Sarcopenia and Lower Urinary Tract Diseases: Links, Mechanisms, and Clinical Implications. Frontiers in Nutrition, 12, Article 1704456. [Google Scholar] [CrossRef]
|
|
[13]
|
Bellos, T.C., Tzelves, L.I., Manolitsis, I.S., Katsimperis, S.N., Berdempes, M.V., Skolarikos, A., et al. (2022) Frailty and Benign Prostatic Hyperplasia: The Thrilling Underlying Impact. Archivio Italiano di Urologia e Andrologia, 94, 345-349. [Google Scholar] [CrossRef] [PubMed]
|